Second-line therapy.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D019772:Topotecan; D017211:Treatment Failure
D000970:Antineoplastic Agents; D019772:Topotecan; D002166:Camptothecin